Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001178913-24-003877
Filing Date
2024-11-29
Accepted
2024-11-29 15:04:59
Documents
1
Group Members
KOBI GEORGE

Document Format Files

Seq Description Document Type Size
1 SC 13D/A zk2432412.htm SC 13D/A 54182
  Complete submission text file 0001178913-24-003877.txt   55707
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Subject) CIK: 0001534248 (see all company filings)

EIN.: 813676773 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86953 | Film No.: 241516172
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 15 KAFRISIN ST. TEL AVIV L3 6901658
Business Address
Mor George Adi (Filed by) CIK: 0001851069 (see all company filings)

Type: SC 13D/A